Vanguard Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Hold |
|
|||||
|
2025
Q1 | $30.4K | Hold |
|
|||||
|
2024
Q4 | $39.8K | Sell |
|
|||||
|
2024
Q3 | $149K | Sell |
|
|||||
|
2024
Q2 | $440K | Hold |
|
|||||
|
2024
Q1 | $1.14M | Sell |
|
|||||
|
2023
Q4 | $667K | Hold |
|
|||||
|
2023
Q3 | $1.24M | Buy |
|
|||||
|
2023
Q2 | $4.65M | Sell |
|
|||||
|
2023
Q1 | $5.77M | Buy |
|
|||||
|
2022
Q4 | $5.94M | Sell |
|
|||||
|
2022
Q3 | $15.8M | Sell |
|
|||||
|
2022
Q2 | $11.5M | Sell |
|
|||||
|
2022
Q1 | $7.03M | Sell |
|
|||||
|
2021
Q4 | $12.7M | Sell |
|
|||||
|
2021
Q3 | $22.5M | Sell |
|
|||||
|
2021
Q2 | $41.7M | Sell |
|
|||||
|
2021
Q1 | $57.8M | Buy |
|
|||||
|
2020
Q4 | $40.2M | Buy |
|
|||||
|
2020
Q3 | $38.5M | Sell |
|
|||||
|
2020
Q2 | $50.8M | Buy |
|
|||||
|
2020
Q1 | $37.1M | Buy |
|
|||||
|
2019
Q4 | $59.4M | Buy |
|
|||||
|
2019
Q3 | $47.8M | Sell |
|
|||||
|
2019
Q2 | $65.6M | Buy |
|
|||||
|
2019
Q1 | $38.8M | Buy |
|
|||||
|
2018
Q4 | $10.4M | Sell |
|
|||||
|
2018
Q3 | $28.1M | Buy |
|
|||||
|
2018
Q2 | $25.9M | Buy |
|
|||||
|
2018
Q1 | $33M | Sell |
|
|||||
|
2017
Q4 | $35.2M | Buy |
|
|||||
|
2017
Q3 | $50.3M | Buy |
|
|||||
|
2017
Q2 | $48.9M | Buy |
|
|||||
|
2017
Q1 | $46.3M | Buy |
|
|||||
|
2016
Q4 | $37M | Buy |
|
|||||
|
2016
Q3 | $37.8M | Sell |
|
|||||
|
2016
Q2 | $36.9M | Buy |
|
|||||
|
2016
Q1 | $48.8M | Buy |
|
|||||
|
2015
Q4 | $53.1M | Buy |
|
|||||
|
2015
Q3 | $39.8M | Buy |
|
|||||
|
2015
Q2 | $50.5M | Buy |
|
|||||
|
2015
Q1 | $33.8M | Buy |
|
|||||
|
2014
Q4 | $13.8M | Buy |
|
|||||
|
2014
Q3 | $7.1M | Sell |
|
|||||
|
2014
Q2 | $11.5M | Buy |
|
|||||
|
2014
Q1 | $11.6M | Buy |
|
|||||
|
2013
Q4 | $10.5M | Buy |
|
|||||
|
2013
Q3 | $8.17M | Buy |
|
|||||
|
2013
Q2 | $3.85M | Buy |
|